. 2021 May 17;43(4):547–558. doi: 10.1111/ijlh.13582

TABLE 2.

Summary of data from Table 1

Cohort		Parameter
Cohort		Age	4Ts	ELISA OD	CLIA (U/mL)
All cases	Median	61	5	0.67	1.9
All cases	IQR	50‐70	4‐6	0.47‐1.20	1.9‐18.5
Functional +ve cases	Median	61	6	1.02	21.0
Functional ‐ve cases	Median	58	4	0.59	0.35

		M	F	UFH	LMWH
All cases	n (%)	43 (75.4)	14 (24.6)	34 (55.7)	27 (44.3)
Functional +ve cases	n (%)	12 (70.6)	5 (29.4)	11 (45.8)	13 (54.2)
Functional ‐ve cases	n (%)	13 (68.4)	6 (31.6)	4 (40.0)	6 (60.0)

UFH

LMWH

All cases

n (%)

43 (75.4)

14 (24.6)

34 (55.7)

27 (44.3)

Functional

+ve cases

n (%)

12 (70.6)

5 (29.4)

11 (45.8)

13 (54.2)

Functional ‐ve cases

n (%)

13 (68.4)

6 (31.6)

4 (40.0)

6 (60.0)

Abbreviations: 4T, 4T score; ELISA, enzyme‐linked immunosorbent assay; CLIA, chemiluminescence immunoassay; LIA, latex immunoassay; M, male; F, female; UFH, unfractionated heparin; LMWH, low molecular weight heparin; IQR, interquartile range.